Sean N. Doherty
Chief Executive Officer at BC XII Private Investors (Lux) SCSP
Profile
Sean Doherty is the Founder of the T1D Fund and former Chair of the Board who led the concept-creation, design and capital financing of the Fund, and he has driven its strategy since inception..
Sean retired at the end of 2018 from his role as Managing Director of Bain Capital, LP, a private global investment firm which he joined in 2005 as the firm’s first general counsel.
In this role he built a pioneering and industry-leading deal lawyer and risk management group during a time of rapid growth and institutionalization of the alternative asset industry.
He also had a diverse operational and constituency management role at Bain Capital, where he led crisis management, press and external communications, government relations, branding and philanthropic initiatives and was deeply involved in governance matters and capital raising.
Earlier in his career he worked at Ropes & Gray LLP and was a law clerk to a federal district judge in Boston.
Prior to law school, he was a Lieutenant in the U.S.
Navy, in which he served on a Middle East Force frigate from 1990-94.
Sean and his wife, Suzy, have been involved with JDRF since 2002 when their son Finn was diagnosed with T1D at the age of 2.
He served on the JDRF International Board and its Executive Committee from 2016 to 2019 following more than a decade of service on the JDRF New England Chapter Board, including two years as its President.
He received a J.D.
magna cum laude from Harvard Law School and a B.A.
magna cum laude in Government from Harvard College.
He serves on the boards of directors of two companies with T1D programs and is also a member of the board of trustees of Thayer Academy in Braintree, MA.
Sean N. Doherty active positions
| Companies | Position | Start |
|---|---|---|
BC XII Private Investors (Lux) SCSP
 BC XII Private Investors (Lux) SCSP Investment ManagersFinance BC XII Private Investors (Lux), SCSp operates as private equity fund. The company is headquartered in Findel, Luxembourg. | Chief Executive Officer | - |
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | - |
Former positions of Sean N. Doherty
| Companies | Position | End |
|---|---|---|
| PROVENTION BIO, INC. | Director/Board Member | 2021-12-31 |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | Director/Board Member | 2021-12-30 |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Director/Board Member | 2019-12-30 |
Bain Capital LP
 Bain Capital LP Financial ConglomeratesFinance Bain Capital LP engages in provision of investment consulting services. It specializes in private equity, credit, public equity, venture, real estate, double impact, life sciences, and partnership strategies. The company was founded in 1984 and is headquartered in Boston, MA. | General Counsel | 2018-12-30 |
| United States Navy (District of Columbia) | Corporate Officer/Principal | 1993-12-31 |
Training of Sean N. Doherty
| Harvard Law School | Graduate Degree |
| Harvard College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Bain Capital LP
Bain Capital LP Financial ConglomeratesFinance Bain Capital LP engages in provision of investment consulting services. It specializes in private equity, credit, public equity, venture, real estate, double impact, life sciences, and partnership strategies. The company was founded in 1984 and is headquartered in Boston, MA. | Finance |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Commercial Services |
| United States Navy (District of Columbia) | Government |
Trustees of Thayer Academy
 Trustees of Thayer Academy Miscellaneous Commercial ServicesCommercial Services The Thayer Academy provides educational services. It regulates student enrollment requirements and establishes educational standards, procedures, and curriculum. The firm offers college preparatory education that attracts students from diverse social, ethnic, economic, and academic backgrounds. The company was founded in 1877 and is headquartered in Braintree, MA. | Commercial Services |
Ropes & Gray LLP
 Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Commercial Services |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
BC XII Private Investors (Lux) SCSP
BC XII Private Investors (Lux) SCSP Investment ManagersFinance BC XII Private Investors (Lux), SCSp operates as private equity fund. The company is headquartered in Findel, Luxembourg. | Finance |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Finance |
| JDRF New England Chapter |
- Stock Market
- Insiders
- Sean N. Doherty
